PharVision Advisers’s Harmonic Inc HLIT Stock Holding History

PharVision Advisers’s Portfolio HLIT Stock Details HLIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,461	Closed	-$138K	–	383
2024 Q4	$138K	Buy	+10,461	New	+$136K	0.12%	353

Other funds holding HLIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's HLIT Position: Q1 2025 in Review

PharVision Advisers sold out of Harmonic Inc (HLIT) in Q1 2025, closing a stake of 10,461 shares — an estimated $138K sold.

PharVision Advisers first reported a position in HLIT in Q4 2024 and held it in 1 quarter. The position peaked at $138K in Q4 2024. 247 funds tracked by Wall St. Rank hold HLIT as of Q1 2025.

PharVision Advisers reported no remaining Harmonic Inc position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 10,461 Harmonic Inc shares in Q1 2025, an estimated $138K.
PharVision Advisers first reported a position in Harmonic Inc in Q4 2024 and held it in 1 quarter.
PharVision Advisers's Harmonic Inc position peaked at $138K in Q4 2024.
247 funds tracked by Wall St. Rank held Harmonic Inc as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.